Great summary mate. Thinking exact same. There is only $70k total value in sell side up to 44c in a $104M company.. It will push through and a re-rate once we know the metrics. Hopefully exceed the second guidance… I would think so or high side.
The change in tact and clinical evidence is compelling. IV is a global leader with runs on the board..
Very happy.
cheers
Monty
Great summary mate. Thinking exact same. There is only $70k...
Add NXS (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
25.0¢ |
Change
-0.005(1.96%) |
Mkt cap ! $72.92M | |||
| Open | High | Low | Value | Volume |
| 25.5¢ | 25.5¢ | 25.0¢ | $4.813K | 18.91K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 18954 | 25.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 26.0¢ | 23171 | 4 |
View Market Depth
| Last trade - 16.10pm 30/05/2024 (20 minute delay) ? |
|
|||||
|
Last
25.0¢ |
Change
-0.005 ( 1.96 %) |
||||
| Open | High | Low | Volume | ||
| 25.0¢ | 25.5¢ | 25.0¢ | 17323 | ||
| Last updated 15.59pm 30/05/2024 ? | |||||
| NXS (ASX) Chart |